Showing 1-10 of about 196 articles.
Research and Markets
Dublin, Jan. 15, 2021 (GLOBE NEWSWIRE) -- The "Europe Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market 2020-2030 by Category, Service Type (CMO, CRO), Therapeutic...
Research and Markets
Dublin, Jan. 14, 2021 (GLOBE NEWSWIRE) -- The "Small Molecule Drug Product Contract Manufacturer Quality Benchmarking (4th Edition)" report has been added to ResearchAndMarkets.com's offering. ...
Research and Markets
Dublin, Jan. 14, 2021 (GLOBE NEWSWIRE) -- The "Small Molecule API Contract Manufacturer Quality Benchmarking (6th Edition)" report has been added to ResearchAndMarkets.com's offering. The Small...
Research and Markets
Dublin, Jan. 12, 2021 (GLOBE NEWSWIRE) -- The "North America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market 2020-2030 by Category, Service Type (CMO, CRO),...
Research and Markets
Dublin, Jan. 11, 2021 (GLOBE NEWSWIRE) -- The "Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market 2020-2030 by Category, Service Type (CMO, CRO),...
Research and Markets
Dublin, Jan. 07, 2021 (GLOBE NEWSWIRE) -- The "Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market 2020-2030 by Category, Service Type (CMO, CRO), Therapeutic...
Research and Markets
Dublin, Jan. 05, 2021 (GLOBE NEWSWIRE) -- The "ADC Contract Manufacturing Market (4th Edition) by Phase of Development, Type of Component Manufacturing, Target Indications, Type of Payload Used,...
Research and Markets
Dublin, Jan. 05, 2021 (GLOBE NEWSWIRE) -- The "Global Pharmaceutical Contract Development & Manufacturing Market (2020-2025) by Service, End User, Geography, Competitive Analysis and the Impact...
Martech Record
New York, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Martech Record, the first and only independent authority on the partnership marketing space, today released the first ever affiliate marketing buyer’s...
Equillium
LA JOLLA, Calif., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ) a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders,...
Showing 1-10 of about 196 articles.